MENU
+Compare
IHE
ETF ticker: NYSE ARCA
AS OF
Jan 23, 04:59 PM (EDT)
Price
$86.75
Change
-$0.83 (-0.95%)
Net Assets
984.62M

IHE stock forecast, quote, news & analysis

The investment seeks to track the investment results of the Dow Jones U... Show more

Category: #Health
IHE
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for IHE with price predictions
Jan 22, 2026

Aroon Indicator for IHE shows an upward move is likely

IHE's Aroon Indicator triggered a bullish signal on January 20, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 248 similar instances where the Aroon Indicator showed a similar pattern. In of the 248 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 13, 2026. You may want to consider a long position or call options on IHE as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IHE just turned positive on January 22, 2026. Looking at past instances where IHE's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IHE advanced for three days, in of 333 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IHE moved out of overbought territory on December 16, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IHE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN).

Industry description

The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.

Market Cap

The average market capitalization across the iShares US Pharmaceuticals ETF ETF is 56.42B. The market cap for tickers in the group ranges from 318.91M to 952.56B. LLY holds the highest valuation in this group at 952.56B. The lowest valued company is EOLS at 318.91M.

High and low price notable news

The average weekly price growth across all stocks in the iShares US Pharmaceuticals ETF ETF was 27%. For the same ETF, the average monthly price growth was 54%, and the average quarterly price growth was 211%. CORT experienced the highest price growth at 17%, while HROW experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the iShares US Pharmaceuticals ETF ETF was -14%. For the same stocks of the ETF, the average monthly volume growth was 10% and the average quarterly volume growth was 57%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 66
Price Growth Rating: 45
SMR Rating: 72
Profit Risk Rating: 73
Seasonality Score: 10 (-100 ... +100)
View a ticker or compare two or three
IHE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com